USFDA inspects Divi’s Laboratories’ Unit-I facility at Telangana

15 Nov 2019 Evaluate

Divi’s Laboratories’ Unit-I facility at Lingojigudem, Bhuvanagiri Yadadri District, Telangana has been inspected by the US Food and Drug Administration (USFDA) from the November 11, 2019 to November 15, 2019. This inspection was a general cGMP inspection by the USFDA. The inspection has been concluded with no 483 observations.

Divis Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates. The company in a matter of short time expanded its breadth of operations to provide complete turnkey solutions to the domestic Indian pharmaceutical industry.


Divis Lab Share Price

3918.75 6.85 (0.18%)
18-May-2024 12:50 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1532.85
Dr. Reddys Lab 5812.50
Cipla 1403.90
Zydus Lifesciences 1104.45
Lupin 1661.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.